Neoadjuvant Chemo Adds Significant Treatment Benefit in Penile Cancer
In a recent study, median overall survival with neoadjuvant chemotherapy, lymphadenectomy was 37.0 months
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.